Oct27Fri

Member News from ICON

ICON and the International Consortium for Health Outcomes Measurement unveil the world’s first global patient outcomes benchmarking platform

Dublin, Ireland, 27 October 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the mission of driving value based health care, shared the findings of a global patient outcomes benchmarking platform at this week’s ICHOM’s annual conference in Washington DC. The platform aims to catalyse physician driven learning and improvement of the outcomes that matter most to patients.

ICON and ICHOM first partnered to advance value-based healthcare through the launch of a global healthcare outcomes benchmarking pilot program called GLOBE in March 2016.

Read More

Oct26Thu

Member News from Udaras company, CLS

EY Awards: CLS head Evelyn O’Toole named industry entrepreneur of the year
The Irish Times

Evelyn O’Toole, founder and chief executive of Co Galway-based Complete Laboratory Solutions (CLS), the largest privately owned contract laboratory in the country, has been named EY Industry Entrepreneur of the Year.

The Clifden native set up the company in the village of Ros Muc in the heart of Connemara in 1994 just a week after being made redundant when the laboratory she was working in burnt down.

“To win is fantastic. Obviously, it is a huge personal accolade but it is also great for the team who have helped make CLS an ongoing success,” said Ms O’Toole.

Read More

Oct26Thu

For Immediate Release

  

FOR IMMEDIATE RELEASE

Irish American Business Chamber and ICON Clinical Research partner to present Life Sciences Forum

Philadelphia, PA, October 26, 2017 – The Irish American Business Chamber & Network has announced that it will partner with Ambassador Club member, ICON Clinical Research, to present their third annual Life Sciences Forum on November 16th at ICON’s largest US office in North Wales, PA. The forum is proudly sponsored by Aer Lingus.

Key note speaker, Dr. Garret FitzGerald, Director, Institute for Translational Medicine & Therapeutics at the University of Pennsylvania and winner of the prestigious Science Foundation Ireland St. Patrick’s Day Medal, will open the forum. The dynamic panel will feature Dr. Andrea Perrone, MD, Associate Vice President, Clinical Imaging Translational Medicine at Merck & Co and Mr. Joseph Sirianni, Senior Director Global Engineering Services, Zoetis, and will be moderated by Paul McCracken Ph.D., Vice President, Head of Medical Imaging, ICON plc.

Read More

Oct24Tue

PA Trade Mission in Co. Mayo

#IABCN members, Joe Burke (center) and Michael O’Rourke (far right) representing PA Trade Mission, meeting with Mayo County Council Economic Development Group this week.

PA Trade Mission visit to the McHale headquarters, just outside Ballinrobe, County Mayo.

#IABCN member, Joe Burke (2nd to left) with 2 Mayo County Council Economic Development Reps and (3rd from left) Paul McHale, Sales Manager; (center) Gene Barr, President & CEO of PA Chamber of Business and Industry; (2nd from right) Padraic McHale, Co-Owner and Founder.

McHale employs 250+, with 25% of their workforce is dedicated to R&D.

Oct24Tue

Member News from Almac Group

Almac Group Introduces Accountability and Reconciliation Tracking Fully Configurable Extension of IXRS®3 Provides End-to-End Traceability of IMP

Souderton, PA – 24 October 2017 – Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data, has extended the functionality of its industry-leading IXRS® 3 IRT platform to include Accountability and Reconciliation Tracking (ART™).

ART captures all accountability data relating to the assignment, dispensation, and return of investigational medicinal products (IMP) throughout the course of a clinical trial. The toolkit provides total control over—and visibility into—the entire chain of custody down to the individual IMP unit level. This improves trial oversight, reduces dispensation errors, and strengthens patient safety.

Read More